🇺🇸 FDA
Patent

US 8435575

Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

granted A61KA61K31/047A61K31/121

Quick answer

US patent 8435575 (Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy) held by Aphios Corporation expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aphios Corporation
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/047, A61K31/121, A61K36/9068, A61P